TMC Life Sciences Bhd (XKLS:0101) Cyclically Adjusted Revenue per Share: RM0.16 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0101 TMC Life Sciences Bhd XKLS:0101
60 GF Score
Price RM0.47
GF Value RM0.62
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is TMC Life Sciences Bhd Cyclically Adjusted Revenue per Share?

TMC Life Sciences Bhd XKLS:0101 60 Cyclically Adjusted Revenue per Share is RM0.16 as of Mar. 2026. GuruFocus rates XKLS:0101 with a GF Score™ of 60/100 and a GF Value™ of RM0.62 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

TMC Life Sciences Bhd's adjusted revenue per share for the three months ended in Mar. 2026 was RM0.051. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is RM0.16 for the trailing ten years ended in Mar. 2026.

During the past 12 months, TMC Life Sciences Bhd's average Cyclically Adjusted Revenue Growth Rate was -69.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -31.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of TMC Life Sciences Bhd was 5.70% per year. The lowest was -31.70% per year. And the median was -13.00% per year.

As of today (2026-07-16), TMC Life Sciences Bhd's current stock price is RM0.47. TMC Life Sciences Bhd's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was RM0.16. TMC Life Sciences Bhd's Cyclically Adjusted PS Ratio of today is 2.94.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of TMC Life Sciences Bhd was 3.73. The lowest was 0.75. And the median was 1.27.


TMC Life Sciences Bhd  (XKLS:0101) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

TMC Life Sciences Bhd's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.47/0.16
=2.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of TMC Life Sciences Bhd was 3.73. The lowest was 0.75. And the median was 1.27.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


TMC Life Sciences Bhd Cyclically Adjusted Revenue per Share Related Terms


TMC Life Sciences Bhd Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for TMC Life Sciences Bhd's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMC Life Sciences Bhd Cyclically Adjusted Revenue per Share Chart

TMC Life Sciences Bhd Annual Data
Trend May15 May16 Aug17 Aug18 Aug19 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.47 0.49 0.52 0.15

TMC Life Sciences Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.53 0.15 0.15 0.15 0.16

XKLS:0101 vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TMC Life Sciences Bhd Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where TMC Life Sciences Bhd's Cyclically Adjusted PS Ratio falls into.


XKLS:0101
60GF Score
TMC Life Sciences Bhd XKLS:0101
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TMC Life Sciences Bhd Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TMC Life Sciences Bhd's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.051/330.2130*330.2130
=0.051

Current CPI (Mar. 2026) = 330.2130.

TMC Life Sciences Bhd Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201602 0.016 237.111 0.022
201605 0.020 240.229 0.027
201608 0.013 240.849 0.018
201611 0.014 241.353 0.019
201702 0.014 243.603 0.019
201705 0.015 244.733 0.020
201708 0.023 245.519 0.031
201711 0.023 246.669 0.031
201802 0.022 248.991 0.029
201805 0.025 251.588 0.033
201808 0.025 252.146 0.033
201811 0.027 252.038 0.035
201902 0.026 252.776 0.034
201905 0.029 256.092 0.037
201908 0.030 256.558 0.039
201911 0.030 257.208 0.039
202002 0.029 258.678 0.037
202009 0.029 260.280 0.037
202012 0.028 260.474 0.035
202103 0.028 264.877 0.035
202106 0.031 271.696 0.038
202109 0.030 274.310 0.036
202112 0.034 278.802 0.040
202203 0.035 287.504 0.040
202206 0.041 296.311 0.046
202209 0.041 296.808 0.046
202212 0.042 296.797 0.047
202303 0.047 301.836 0.051
202306 0.049 305.109 0.053
202309 0.053 307.789 0.057
202312 0.054 306.746 0.058
202403 0.049 312.332 0.052
202406 0.043 314.175 0.045
202409 0.047 315.301 0.049
202412 0.046 315.605 0.048
202503 0.052 319.799 0.054
202506 0.054 322.561 0.055
202509 0.058 324.800 0.059
202512 0.059 324.054 0.060
202603 0.051 330.213 0.051

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of RM0.16 mean?
TMC Life Sciences Bhd (XKLS:0101) has a Cyclically Adjusted Revenue per Share of RM0.16 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on TMC Life Sciences Bhd and its competitors.
Is TMC Life Sciences Bhd's Cyclically Adjusted Revenue per Share too high?
TMC Life Sciences Bhd's current Cyclically Adjusted Revenue per Share is RM0.16. Overall, TMC Life Sciences Bhd has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's Cyclically Adjusted Revenue per Share compare to HCA and THC?
TMC Life Sciences Bhd's Cyclically Adjusted Revenue per Share of RM0.16 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on TMC Life Sciences Bhd and its competitors. TMC Life Sciences Bhd's current Cyclically Adjusted Revenue per Share is RM0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.62, compared to a current price of RM0.47 — trading 24.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is RM0.16. TMC Life Sciences Bhd's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current Cyclically Adjusted Revenue per Share is RM0.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?

Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued. The current stock price of RM0.47 is trading 24.2% below its estimated GF Value™ of RM0.62. GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0101:

  • Cyclically Adjusted Revenue per Share: RM0.16
  • GF Value™: RM0.62 vs. price of RM0.47 (24.2% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TMC Life Sciences Bhd Business Description

Address No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
60GF Score

Get the complete analysis for XKLS:0101

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.47
Price
RM0.62
GF Value